<DOC>
	<DOC>NCT02767999</DOC>
	<brief_summary>Fluoxetine action on cerebral connectivity changes in acute ischemic stroke patients</brief_summary>
	<brief_title>Serotonin Selective Reuptake Inhibitor (SSRI) Effects on Cerebral Connectivity in Acute Ischemic Stroke</brief_title>
	<detailed_description>In this placebo-controlled study, using functional resting state MRI, the investigators aim to investigate cerebral connectivity changes induced by fluoxetine given once a day for 90 days, in stroke patients with a moderate to severe motor deficit.</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<criteria>Firstever ischemic stroke Cortical or subcortical stroke National Institute of Health Stroke Scale NIHSS&gt;12 or motor NIHSS&gt;6 at inclusion MRIproved ischemic stroke pregnant or breastfeeding women alcoholism ongoing Selective Serotonin Reuptake Inhibitor treatment or interruption &lt; 1 month allergic reaction after SSRI administration MRI contraindication NIHSS&gt;22 Severe aphasia Coma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Acute ischemic stroke</keyword>
</DOC>